No Significant Impact of HLA Specific Antibodies (Ab) and Donor Specific Antibodies (DSA) on Heart Transplant Outcome Subsequent to Thymoglobulin induction

被引：0
|
作者：
Cao, K. [1 ]
Coleman, B. [1 ]
Czer, L. S. [1 ]
Simsir, S. [1 ]
Schwarz, E. [1 ]
Lai, C-H [1 ]
Ong, G. [1 ]
Wang, Q. [1 ]
Naim, M. [1 ]
Reinsmoen, N. L. [1 ]
机构：
[1] Cedars Sinai Hlth Syst, Los Angeles, CA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2009年 / 28卷 / 02期
关键词：
D O I：
10.1016/j.healun.2008.11.566
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
559
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [31] Intravenous immunglobulin (IVIG) and thymoglobulin induction treatment downregulates preformed donor-specific Anti-HLA antibodies (DSA), but does not prevent the development of De Novo DSA.
    Akalin, E
    Fotino, M
    Friedlander, R
    Murphy, B
    Ames, S
    Sehgal, V
    Daly, L
    Bromberg, JS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 438A - 438A
  • [32] Intravenous immunglobulin (IVIG) and thymoglobulin induction treatment downregulate preformed donor-specific anti-HLA antibodies (DSA), but do not prevent the development of de novo DSA.
    Akalin, E
    Fotino, M
    Friedlander, R
    Murphy, B
    Ames, S
    Sehgal, V
    Daly, L
    Bromberg, JS
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 550 - 551
  • [33] The meaning of donor-specific antibodies after heart transplant
    Barten, Markus J.
    Zuckermann, Andreas
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2019, 24 (03) : 252 - 258
  • [34] The Correlation Between Donor Specific Antibodies and Heart Transplant Rejection
    Bedard, R.
    Jindra, P.
    Manson, M.
    Moaddab, M.
    Mallidi, H.
    Etheridge, W.
    Civitello, A.
    Kerman, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [35] Heart Transplantation in Sensitized Recipients, the Impact of Pre-Transplant Donor-Specific Antibodies on Clinical Outcome
    Sareyyupoglu, B.
    Toyoda, Y.
    Fujimoto, K.
    Teuteberg, J. J.
    Shullo, M. A.
    Zaldonis, D.
    Bonde, P.
    Bhama, J. K.
    Bermudez, C.
    Kormos, R. L.
    Zeevi, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S21 - S22
  • [36] The Impact of De Novo Donor Specific Anti-HLA Antibodies on the 5-Year Renal Transplant Outcome
    Banasik, M.
    Boratynska, M.
    Koscielska-Kasprzak, K.
    Zabinska, M.
    Chudoba, P.
    Patrzalek, D.
    Halon, A.
    Klinger, M.
    TRANSPLANTATION, 2012, 94 (10) : 1051 - 1051
  • [37] Timing and Persistence of Pre Transplant Donor Specific Antibodies (DSA) and Impact On Renal Allograft Outcomes.
    Adebiyi, O.
    Gralla, J.
    Wiseman, A.
    Patrick, K.
    Cooper, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 562 - 563
  • [38] Timing and Persistence of Pre Transplant Donor Specific Antibodies (DSA) and Impact On Renal Allograft Outcomes.
    Adebiyi, O.
    Gralla, J.
    Wiseman, A.
    Patrick, K.
    Cooper, J.
    TRANSPLANTATION, 2014, 98 : 562 - 563
  • [39] Increased Negative Impact of Anti-Angiotensin Type 1 Receptor Antibodies Together with De Novo Donor HLA Specific Antibodies on Graft Outcome in Heart Transplant Recipients
    Reinsmoen, N. L.
    Lai, C-H
    Mirocha, J.
    Cao, K.
    Ong, G. D.
    Naim, M.
    Wang, Q.
    Riega, S.
    Rafiei, M.
    Patel, J.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S113 - S113
  • [40] Pre-Transplant Non-Cytotoxic Donor Specific HLA Antibodies Do Not Increase the Risk of Graft Dysfunction in Kidney Transplant Recipients with Thymoglobulin and IVIG Induction
    Colovai, A.
    Ajaimi, M.
    Hayde, N.
    Kamal, L.
    Chan, S.
    Savchik, C.
    Rocca, J.
    Akalin, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 534 - 534
12345